tnfr

Infliximab is a monoclonal antibody, a human-mouse chimeric monoclonal antibody that inhibits TNF-α and prevents TNF-α from interacting with TNFR1 and TNFR2. Infliximab can be used to treat Crohn's disease and rheumatoid arthritis.

Anti-TNFR-2 CD120b Antibody (3B929) is a Rabbit IgG monoclonal antibody targeting Human TNFR-2 CD120b.

Anti-Mouse TNFR2 Antibody is an IgG inhibitor derived from Armenian Hamster, specifically targeting mouse TNFR2.

Anti-mouse TNFR2 anti-host is rat, which can be used for FC, BLI, block and other related studies. The isotype control subtype is rat IgG2a.

Anti-TNFR2 CD120b TNFR1B Antibody (6I44) is a Rabbit IgG monoclonal antibody targeting Mouse TNFR2 CD120b TNFR1B.

Anti-TNFR1 CD120a TNFRSF1A Antibody (9Z795) is a Rabbit IgG monoclonal antibody targeting Human TNFR1 CD120a TNFRSF1A.

Etanercept is a fusion protein consisting of the soluble portion of the p75-tumor necrosis factor receptor (TNFR) and the Fc fragment of human IgG1 and is commonly used to treat patients with rheumatoid arthritis.[1]

Ragifilimab (INCAGN-1876) is an agonist monoclonal antibody that targets glucocorticoid-induced TNFR-associated protein (GITR) and can be used in the study of advanced or metastatic solid tumors.

Tulinercept (OPRX-106), a monoclonal antibody, may be utilized in a range of biochemical research applications [1].

Anti-Mouse CD40 Antibody (FGK4.5 FGK45) is a rat-derived IgG2a monoclonal antibody targeting mouse CD40, a type I transmembrane glycoprotein within the tumor necrosis factor receptor (TNFR) superfamily. CD40 functions as a costimulatory molecule, activating B cells, dendritic cells, monocytes, and other antigen-presenting cells (APC), thereby enhancing antitumor T cell responses.